Antimicrobial resistance in orthopedics: microbial insights, clinical impact, and the necessity of a multidisciplinary approach—a review
DOI:
https://doi.org/10.2340/17453674.2025.43477Keywords:
Antimicrobial resistance, Implants, Infection, Osteomyelitis, PJIAbstract
Antimicrobial resistance (AMR) is rising globally and is a threat and challenge for orthopedic surgery, particularly in managing prosthetic joint infections (PJIs). This review first explores several AMR mechanisms from a microbiological point of view, including selective pressure, horizontal gene transfer, and further dissemination. Second, the variation in the rise of AMR across countries is highlighted, including its impact on PJI. While countries with the highest AMR rates are expected to experience the most significant burden, no country will be immune to the increasing prevalence of PJI. Third, this review stresses that multidimensional strategies are needed to combat AMR’s challenges in orthopedic surgery. These include raising awareness across all sectors, including healthcare professionals, the public, healthcare policymakers, and even politicians; advancing diagnostic technologies for early infection detection and classification of resistant or susceptible strains; promoting antibiotic stewardship; and developing new material technologies to prevent or cure PJI. This review highlights the urgent need for a coordinated response from clinicians, researchers, and policymakers to avoid AMR-related complications in PJI cases.
Downloads
References
European Commission. AMR: a major European and Global challenge. 2017. Available from: https://ec.europa.eu/health/sites/default/files/antimicrobial_resistance/docs/amr_2017_factsheet.pdf
Endale H, Mathewos M, Abdeta D. Potential causes of spread of antimicrobial resistance and preventive measures in one health perspective: a review. Infect Drug Resist 2023; 16: 7515-45. doi: 10.2147/idr.s428837. DOI: https://doi.org/10.2147/IDR.S428837
Murray C J, Ikuta K S, Sharara F, Swetschinski L, Aguilar G R, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629-55. doi: 10.1016/S0140-6736(21)02724-0. DOI: https://doi.org/10.1016/S0140-6736(21)02724-0
O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Wellcome Trust 2017. Available from: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf
Naghavi M, Vollset S E, Ikuta K S, Swetschinski L R, Gray A P, Wool E E, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 2024; 404: 1199-226. doi: 10.1016/s0140-6736(24)01867-1. DOI: https://doi.org/10.1016/S0140-6736(24)01867-1
Sabah S A, Alvand A, Price A J. Revision knee replacement for prosthetic joint infection: epidemiology, clinical outcomes and health-economic considerations. Knee 2021; 28: 417-21. doi: 10.1016/j.knee.2020.12.024. DOI: https://doi.org/10.1016/j.knee.2020.12.024
Klug A, Gramlich Y, Rudert M, Drees P, Hoffmann R, Weissenberger M, et al. The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years. Knee Surg Sports Traumatol Arthrosc 2021; 29: 3287-98. doi: 110.1007/s00167-020-06154-7. DOI: https://doi.org/10.1007/s00167-020-06154-7
Parvizi J, Fassihi S C, Enayatollahi M A. Diagnosis of periprosthetic joint infection following hip and knee arthroplasty. Orthop Clin North Am 2016; 47: 505-55 doi: 10.1016/j.ocl.2016.03.001. DOI: https://doi.org/10.1016/j.ocl.2016.03.001
Corvec S, Portillo M E, Pasticci B M, Borens O, Trampuz A. Epidemiology and new developments in the diagnosis of prosthetic joint infection. Int J Artif Organs 2012; 35: 923-34. doi: 10.5301/ijao.5000168. DOI: https://doi.org/10.5301/ijao.5000168
Del Pozo J L, Patel R. Infection associated with prosthetic joints. N Engl J Med 2009; 361: 787-94. doi: 10.1056/NEJMcp0905029. DOI: https://doi.org/10.1056/NEJMcp0905029
Davidson D J, Spratt D, Liddle A D. Implant materials and prosthetic joint infection: the battle with the biofilm. EFORT Open Rev 2019; 4: 633-9. doi: 10.1302/2058-5241.4.180095. DOI: https://doi.org/10.1302/2058-5241.4.180095
Aggarwal V K, Rasouli M R, Parvizi J. Periprosthetic joint infection: current concept. Indian J Orthop 2013; 47: 10-7. doi: 10.4103/0019-5413.106884 DOI: https://doi.org/10.4103/0019-5413.106884
Hogan A, Heppert V G, Suda A J. Osteomyelitis. Arch Orthop Trauma Surg 2013; 133: 1183-96. doi: 10.1007/s00402-013-1785-7. DOI: https://doi.org/10.1007/s00402-013-1785-7
Trampuz A, Widmer A F. Infections associated with orthopedic implants. Curr Opin Infect Dis 2006; 19: 349-56. doi: 10.1097/01.qco.0000235161.85925.e8. DOI: https://doi.org/10.1097/01.qco.0000235161.85925.e8
Wei H, Song X, Liu P, Liu X, Yan X, Yu L. Antimicrobial coating strategy to prevent orthopaedic device-related infections: recent advances and future perspectives. Biomater Adv 2022; 135: 212739. doi: 10.1016/j.bioadv.2022.212739. DOI: https://doi.org/10.1016/j.bioadv.2022.212739
Xu Y, Huang T B, Schuetz M A, Choong P F. Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection. EFORT Open Reviews 2023; 8: 690-7. doi: 10.1530/EOR-23-0078. DOI: https://doi.org/10.1530/EOR-23-0078
Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg 2004; 188: 57-66. doi: 10.1016/S0002-9610(03)00292-7. DOI: https://doi.org/10.1016/S0002-9610(03)00292-7
Geurts J, Arts J C, Walenkamp G. Bone graft substitutes in active or suspected infection: contra-indicated or not? Injury 2011; 42: S82-S86. doi: 10.1016/j.injury.2011.06.189. DOI: https://doi.org/10.1016/j.injury.2011.06.189
Conterno L O, Turchi M D. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev 2013; 2013(9): CD004439. doi: 10.1002/14651858.CD004439.pub3. DOI: https://doi.org/10.1002/14651858.CD004439.pub3
Mortazavi J S, Schwartzenberger J, Austin M S, Purtill J J, Parvizi J. Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res 2010; 468: 2052-9. doi: 10.1007/s11999-010-1308-6. DOI: https://doi.org/10.1007/s11999-010-1308-6
Salam M A, Al-Amin M Y, Salam M T, Pawar J S, Akhter N, Rabaan A A, et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare (Basel) 2023; 11. doi: 10.3390/healthcare11131946. DOI: https://doi.org/10.20944/preprints202305.0555.v1
Amann S, Neef K, Kohl S. Antimicrobial resistance (AMR). Eur J Hosp Pharm 2019; 26: 175-7. doi: 10.1136/ejhpharm-2018-001820. DOI: https://doi.org/10.1136/ejhpharm-2018-001820
Perron G G, Whyte L, Turnbaugh P J, Goordial J, Hanage W P, Dantas G, et al. Functional characterization of bacteria isolated from ancient arctic soil exposes diverse resistance mechanisms to modern antibiotics. PLoS One 2015; 10: e0069533. doi: 10.1371/journal.pone.0069533. DOI: https://doi.org/10.1371/journal.pone.0069533
D’Costa V M, King C E, Kalan L, Morar M, Sung W W, Schwarz C, et al. Antibiotic resistance is ancient. Nature 2011; 477: 457-61. doi: 10.1038/nature10388. DOI: https://doi.org/10.1038/nature10388
Kolmer J A. Acquired resistance of bacteria to antibiotic compounds. J Am Dent Assoc 1949; 38: 60-6. doi: 10.14219/jada.archive.1949.0018. DOI: https://doi.org/10.14219/jada.archive.1949.0018
Stennett H L, Back C R, Race P R. Derivation of a precise and consistent timeline for antibiotic development. Antibiotics (Basel) 2022; 11. doi: 10.3390/antibiotics11091237. DOI: https://doi.org/10.3390/antibiotics11091237
Davies J. Origins and evolution of antibiotic resistance. Microbiologia 1996; 12: 9-16.
Ochman H, Lawrence J G, Groisman E A. Lateral gene transfer and the nature of bacterial innovation. Nature 2000; 405: 299-304. doi: 10.1038/35012500. DOI: https://doi.org/10.1038/35012500
Baker-Austin C, Wright M S, Stepanauskas R, McArthur J V. Co-selection of antibiotic and metal resistance. Trends Microbiol 2006; 14: 176-82. doi: 10.1016/j.tim.2006.02.006. DOI: https://doi.org/10.1016/j.tim.2006.02.006
Balderrama-González A S, Piñón-Castillo H A, Ramírez-Valdespino C A, Landeros-Martínez L L, Orrantia-Borunda E, Esparza-Ponce H E. Antimicrobial resistance and inorganic nanoparticles. Int J Mol Sci 2021; 22. doi: 10.3390/ijms222312890. DOI: https://doi.org/10.3390/ijms222312890
Lambert P A. Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev 2005; 57: 1471-85. doi: 10.1016/j.addr.2005.04.003. DOI: https://doi.org/10.1016/j.addr.2005.04.003
Wong J L C, Romano M, Kerry L E, Kwong H S, Low W W, Brett S J, et al. OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo. Nat Commun 2019; 10: 3957. doi: 10.1038/s41467-019-11756-y. DOI: https://doi.org/10.1038/s41467-019-11756-y
Lou H, Chen M, Black S S, Bushell S R, Ceccarelli M, Mach T, et al. Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coli. PLoS One 2011; 6: e25825. doi: 10.1371/journal.pone.0025825. DOI: https://doi.org/10.1371/journal.pone.0025825
Poole K. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 2000; 44: 2233-41. doi: 10.1128/aac.44.9.2233-2241.2000. DOI: https://doi.org/10.1128/AAC.44.9.2233-2241.2000
Choi U, Lee C R. Distinct roles of outer membrane porins in antibiotic resistance and membrane integrity in Escherichia coli. Front Microbiol 2019; 10: 953. doi: 10.3389/fmicb.2019.00953. DOI: https://doi.org/10.3389/fmicb.2019.00953
Memar M Y, Yekani M, Celenza G, Poortahmasebi V, Naghili B, Bellio P, et al. The central role of the SOS DNA repair system in antibiotics resistance: a new target for a new infectious treatment strategy. Life Sci 2020; 262: 118562. doi: 10.1016/j.lfs.2020.118562. DOI: https://doi.org/10.1016/j.lfs.2020.118562
Opal S M, Pop-Vicas A. 18—Molecular mechanisms of antibiotic resistance in bacteria. In: Bennett J E, Dolin R, Blaser M J, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases (8th ed.). Philadelphia: W.B. Saunders; 2015. p. 235-51.e233. DOI: https://doi.org/10.1016/B978-1-4557-4801-3.00018-7
Wilson D N, Hauryliuk V, Atkinson G C, O’Neill A J. Target protection as a key antibiotic resistance mechanism. Nat Rev Microbiol 2020; 18: 637-48. doi: 10.1038/s41579-020-0386-z. DOI: https://doi.org/10.1038/s41579-020-0386-z
Costerton J W, Stewart P S, Greenberg E P. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22. doi: 10.1126/science.284.5418.1318. DOI: https://doi.org/10.1126/science.284.5418.1318
Bhattacharya M, Wozniak D J, Stoodley P, Hall-Stoodley L. Prevention and treatment of Staphylococcus aureus biofilms. Expert Rev Anti Infect Ther 2015; 13: 1499-516. doi: 10.1586/14787210.2015.1100533. DOI: https://doi.org/10.1586/14787210.2015.1100533
Flemming H C, Baveye P, Neu T R, Stoodley P, Szewzyk U, Wingender J, et al. Who put the film in biofilm? The migration of a term from wastewater engineering to medicine and beyond. NPJ Biofilms Microbiomes 2021; 7: 10. doi: 10.1038/s41522-020-00183-3. DOI: https://doi.org/10.1038/s41522-020-00183-3
Marathe N P, Bank M S. The microplastic-antibiotic resistance connection. In: Bank M S, editor. Microplastic in the environment: pattern and process. New York: Springer; 2022. p. 311-22. DOI: https://doi.org/10.1007/978-3-030-78627-4_9
Villa J M, Pannu T S, Theeb I, Buttaro M A, Oñativia J I, Carbo L, et al. International organism profile of periprosthetic total hip and knee infections. J Arthroplasty 2021; 36: 274-8. doi: 10.1016/j.arth.2020.07.020. DOI: https://doi.org/10.1016/j.arth.2020.07.020
Rumbaugh K P, Sauer K. Biofilm dispersion. Nat Rev Microbiol 2020; 18: 571-86. doi: 10.1038/s41579-020-0385-0. DOI: https://doi.org/10.1038/s41579-020-0385-0
Madsen J S, Burmølle M, Hansen L H, Sørensen S J. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol 2012; 65: 183-95. doi: 10.1111/j.1574-695X.2012.00960.x. DOI: https://doi.org/10.1111/j.1574-695X.2012.00960.x
Patel R. Biofilms and antimicrobial resistance. Clin Orthop Relat Res 2005; 74: 41-7. doi: 10.1097/01.blo.0000175714.68624.74. DOI: https://doi.org/10.1097/01.blo.0000175714.68624.74
Brauner A, Fridman O, Gefen O, Balaban N Q. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 2016; 14: 320-30. doi: 10.1038/nrmicro.2016.34. DOI: https://doi.org/10.1038/nrmicro.2016.34
Santi I, Manfredi P, Maffei E, Egli A, Jenal U. Evolution of antibiotic tolerance shapes resistance development in chronic Pseudomonas aeruginosa infections. mBio 2021; 12: e03482-20. doi: 10.1128/mbio.03482-20. DOI: https://doi.org/10.1128/mBio.03482-20
World Health Organization. The evolving threat of antimicrobial resistance: options for action. Geneva: World Health Organization; 2012.
World Health Organization. Global action plan on antimicrobial resistance. 2015. Available from: https://www.who.int/publications/i/item/9789241509763.
Teillant A, Gandra S, Barter D, Morgan D J, Laxminarayan R. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 2015; 15: 1429-37. doi: 10.1016/S1473-3099(15)00270-4. DOI: https://doi.org/10.1016/S1473-3099(15)00270-4
Hafez M A, Zamel F, El-Khadrawi T, El Ganzoury I, Lotfy A M, Fansa M, et al. The rate and management of prosthetic joint infection in the low-income setting: a cross-sectional study. Ann Med Surg 2023; 85: 790-5. doi: 10.1097/ms9.0000000000000430 DOI: https://doi.org/10.1097/MS9.0000000000000430
Kim H S, Park J W, Moon S-Y, Lee Y-K, Ha Y-C, Koo K-H. Current and future burden of periprosthetic joint infection from national claim database. J Korean Med Sci 2020; 35. doi: 10.3346/jkms.2020.35.e410. DOI: https://doi.org/10.3346/jkms.2020.35.e410
Premkumar A, Kolin D A, Farley K X, Wilson J M, McLawhorn A S, Cross M B, et al. Projected economic burden of periprosthetic joint infection of the hip and knee in the United States. J Arthroplasty 2021; 36: 1484-9.e3. doi: 10.1016/j.arth.2020.12.005. DOI: https://doi.org/10.1016/j.arth.2020.12.005
Roth V R, Mitchell R, Vachon J, Alexandre S, Amaratunga K, Smith S, et al. Periprosthetic infection following primary hip and knee arthroplasty: the impact of limiting the postoperative surveillance period. Infect Control Hosp Epidemiol 2017; 38: 147-53. doi: 10.1017/ice.2016.256. DOI: https://doi.org/10.1017/ice.2016.256
Panula V J, Alakylä K J, Venäläinen M S, Haapakoski J J, Eskelinen A P, Manninen M J, et al. Risk factors for prosthetic joint infections following total hip arthroplasty based on 33,337 hips in the Finnish Arthroplasty Register from 2014 to 2018. Acta Orthop 2021; 92: 665-72. doi: 10.1080/17453674.2021.1944529. DOI: https://doi.org/10.1080/17453674.2021.1944529
Perni S, Bojan B, Prokopovich P. A retrospective study of risk factors, causative micro-organisms and healthcare resources consumption associated with prosthetic joint infections (PJI) using the Clinical Practice Research Datalink (CPRD) Aurum database. PLoS One 2023; 18: e0282709. doi: 10.1371/journal.pone.0282709. DOI: https://doi.org/10.1371/journal.pone.0282709
Lenguerrand E, Whitehouse M R, Beswick A D, Kunutsor S K, Burston B, Porter M, et al. Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study. Lancet Infect Dis 2018; 18: 1004-14. doi: 10.1016/S1473-3099(18)30345-1. DOI: https://doi.org/10.1016/S1473-3099(18)30345-1
Landelijke Registratie Orthopedische Interventies. LROI Report 2024. ‘s Hertogenbosch, the Netherlands; 2024.
Mäkelä K, Hailer N P. Different, yet strong together: the Nordic Arthroplasty Register Association (NARA). Acta Orthop 2021; 92: 635-7. doi: 10.1080/17453674.2021.1947006. DOI: https://doi.org/10.1080/17453674.2021.1947006
Perni S, Prokopovich P. Risk equations for prosthetic joint infections (PJIs) in UK: a retrospective study using the Clinical Practice Research Datalink (CPRD) AURUM and GOLD databases. BMJ open 2024; 14: e082501. doi: 10.1136/bmjopen-2023-082501. DOI: https://doi.org/10.1136/bmjopen-2023-082501
Dale H, Hallan G, Espehaug B, Havelin L I, Engesæter L B. Increasing risk of revision due to deep infection after hip arthroplasty: a study on 97,344 primary total hip replacements in the Norwegian Arthroplasty Register from 1987 to 2007. Acta Orthop 2009; 80: 639-45. doi: 10.3109/17453670903506658. DOI: https://doi.org/10.3109/17453670903506658
Dale H, Høvding P, Tveit S M, Graff J B, Lutro O, Schrama J C, et al. Increasing but levelling out risk of revision due to infection after total hip arthroplasty: a study on 108,854 primary THAs in the Norwegian Arthroplasty Register from 2005 to 2019. Acta Orthop 2021; 92: 208-14. doi: 10.1080/17453674.2020.1851533. DOI: https://doi.org/10.1080/17453674.2020.1851533
SAR Annual report 2023. Gothenburg, Sweden: Swedish Arthroplasty Register; 2023.
Kamp M C, Liu W-Y, Goosen J H, Rijnen W H, van Steenbergen L N, van der Weegen W, et al. Mismatch in capture of periprosthetic joint infections between the Dutch Arthroplasty Register (LROI) and a detailed regional periprosthetic joint infection registry. J Arthroplasty 2022; 37: 126-31. doi: 10.1016/j.arth.2021.09.001. DOI: https://doi.org/10.1016/j.arth.2021.09.001
Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorlí L, et al. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect 2016; 22: 732.e1-8. doi: 10.1016/j.cmi.2016.05.004. DOI: https://doi.org/10.1016/j.cmi.2016.05.004
Hu L, Fu J, Zhou Y, Chai W, Zhang G, Hao L, et al. Trends in microbiological profiles and antibiotic resistance in periprosthetic joint infections. J Int Med Res 2021; 49: 03000605211002784. doi: 10.1177/03000605211002784. DOI: https://doi.org/10.1177/03000605211002784
da Silva R B, Salles M J. Outcomes and risk factors in prosthetic joint infections by multidrug-resistant gram-negative bacteria: a retrospective cohort study. Antibiotics 2021; 10: 340 doi: 10.3390/antibiotics10030340. DOI: https://doi.org/10.3390/antibiotics10030340
Li H-K, Rombach I, Zambellas R, Walker A S, McNally M A, Atkins B L, et al. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med 2019; 380: 425-36. doi: 10.1056/NEJMoa1710926. DOI: https://doi.org/10.1056/NEJMoa1710926
Batty L M, Lanting B. Contemporary strategies to prevent infection in hip and knee arthroplasty. Curr Rev Musculoskelet Med 2020; 13: 400-8. doi: 10.1007/s12178-020-09653-9. DOI: https://doi.org/10.1007/s12178-020-09653-9
Kawamura H, Imuta N, Ooka T, Shigemi A, Nakamura M, Mougi K, et al. Impact of control measures including decolonization and hand hygiene for orthopaedic surgical site infection caused by MRSA at a Japanese tertiary-care hospital. J Hosp Infect 2024; 146: 151-9. doi: 10.1016/j.jhin.2023.07.011. DOI: https://doi.org/10.1016/j.jhin.2023.07.011
Majumder M A A, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, et al. Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist 2020; 13: 4713-38. doi: 10.2147/IDR.S290835. DOI: https://doi.org/10.2147/IDR.S290835
European Centre for Disease Prevention and Control. Surveillance report – Antimicrobial consumption in the EU/EEA (ESAC-Net) – Annual Epidemiological Report for 2022. Stockholm: European Centre for Disease Prevention and Control (ECDC); 2022.
Global Framework for Development & Stewardship to Combat Antimicrobial Resistance: Draft roadmap. Geneva: World Health Organization; 2017.
Moriarty T F, Metsemakers W-J, Morgenstern M, Hofstee M I, Vallejo Diaz A, Cassat J E, et al. Fracture-related infection. Nat Rev Dis Primers 2022; 8: 67. doi: 10.1038/s41572-022-00396-0. DOI: https://doi.org/10.1038/s41572-022-00396-0
Garraghan F. Success of antimicrobial stewardship programmes – it starts with leadership and accountability. Ther Adv Infect Dis 2022; 9: 20499361221139594. doi: 10.1177/20499361221139594. DOI: https://doi.org/10.1177/20499361221139594
Huttner B, Harbarth S, Nathwani D; ESCMID Study Group for Antibiotic Policies (ESGAP). Success stories of implementation of antimicrobial stewardship: a narrative review. Clin Microbiol Infect 2014; 20: 954-62. doi: 10.1111/1469-0691.12803. DOI: https://doi.org/10.1111/1469-0691.12803
Craig J, Sriram A, Sadoff R, Bennett S, Bahati F, Beauvais W. Behavior-change interventions to improve antimicrobial stewardship in human health, animal health, and livestock agriculture: a systematic review. PLOS Glob Public Health 2023; 3: e0001526. doi: 10.1371/journal.pgph.0001526. DOI: https://doi.org/10.1371/journal.pgph.0001526
Vonken L, Schneider F, Lejeune B, Noordink A, Kremers S, de Bruijn G J. Perceptions of antibiotic resistance among hospital healthcare professionals in high-income countries: a systematic review of causes, consequences, and solutions. Prev Med 2024; 182: 107953. doi: 10.1016/j.ypmed.2024.107953. DOI: https://doi.org/10.1016/j.ypmed.2024.107953
McCullough A R, Rathbone J, Parekh S, Hoffmann T C, Del Mar C B. Not in my backyard: a systematic review of clinicians’ knowledge and beliefs about antibiotic resistance. J Antimicrob Chemother 2015; 70: 2465-73. doi: 10.1093/jac/dkv164. DOI: https://doi.org/10.1093/jac/dkv164
Harring N, Krockow E M. The social dilemmas of climate change and antibiotic resistance: an analytic comparison and discussion of policy implications. Humanit Soc Sci Commun 2021; 8.s41599-021-00800-2. DOI: https://doi.org/10.1057/s41599-021-00800-2
Tarrant C, Colman A M, Chattoe-Brown E, Jenkins D R, Mehtar S, Perera N, et al. Optimizing antibiotic prescribing: collective approaches to managing a common-pool resource. Clin Microbiol Infect 2019; 25: 1356-63. doi: 10.1016/j.cmi.2019.03.008. DOI: https://doi.org/10.1016/j.cmi.2019.03.008
Bork J T, Heil E L. What is left to tackle in inpatient antimicrobial stewardship practice and research. Infect Dis Clin 2023; 37: 901-15. doi: 10.1016/j.idc.2023.07.003. DOI: https://doi.org/10.1016/j.idc.2023.07.003
World Health Organization. A one health priority research agenda for antimicrobial resistance. Geneva: World Health Organization; 2023.
World Health Organization. Antimicrobial resistance. Geneva: World Health Organization; 2024.
Chanvatik S, Kosiyaporn H, Lekagul A, Kaewkhankhaeng W, Vongmongkol V, Thunyahan A, et al. Knowledge and use of antibiotics in Thailand: a 2017 national household survey. PLoS One 2019; 14: e0220990. doi: 10.1371/journal.pone.0220990. DOI: https://doi.org/10.1371/journal.pone.0220990
Hawkins O, Scott A M, Montgomery A, Nicholas B, Mullan J, van Oijen A, et al. Comparing public attitudes, knowledge, beliefs and behaviours towards antibiotics and antimicrobial resistance in Australia, United Kingdom, and Sweden (2010-2021): a systematic review, meta-analysis, and comparative policy analysis. PLoS One 2022; 17: e0261917. doi: 10.1371/journal.pone.0261917. DOI: https://doi.org/10.1371/journal.pone.0261917
McCullough A, Parekh S, Rathbone J, Del Mar C, Hoffmann T. A systematic review of the public’s knowledge and beliefs about antibiotic resistance. J Antimicrob Chemother 2016; 71: 27-33. doi: 10.1093/jac/dkv310. DOI: https://doi.org/10.1093/jac/dkv310
Machowska A, Stålsby Lundborg C. Drivers of irrational use of antibiotics in Europe. Int J Environ Res Public Health 2018; 16. doi: 10.3390/ijerph16010027. DOI: https://doi.org/10.3390/ijerph16010027
Singh-Phulgenda S, Antoniou P, Wong D L F, Iwamoto K, Kandelaki K. Knowledge, attitudes and behaviors on antimicrobial resistance among general public across 14 member states in the WHO European region: results from a cross-sectional survey. Front Public Health 2023; 11: 1274818. doi: 10.3389/fpubh.2023.1274818. DOI: https://doi.org/10.3389/fpubh.2023.1274818
Krockow E M, Cheng K O, Maltby J, McElroy E. Existing terminology related to antimicrobial resistance fails to evoke risk perceptions and be remembered. Commun Med 2023; 3: 149. doi: 10.1038/s43856-023-00379-6. DOI: https://doi.org/10.1038/s43856-023-00379-6
Mathew P, Sivaraman S, Chandy S. Communication strategies for improving public awareness on appropriate antibiotic use: bridging a vital gap for action on antibiotic resistance. J Family Med Prim Care 2019; 8: 1867-71. doi: 10.4103/jfmpc.jfmpc_263_19. DOI: https://doi.org/10.4103/jfmpc.jfmpc_263_19
Borek A J, Santillo M, Wanat M, Butler C C, Tonkin-Crine S. How can behavioural science contribute to qualitative research on antimicrobial stewardship in primary care? JAC-Antimicrob Resist 2022; 4. doi: 10.1093/jacamr/dlac007. DOI: https://doi.org/10.1093/jacamr/dlac007
Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013; 46: 81-95. doi: 10.1007/s12160-013-9486-6. DOI: https://doi.org/10.1007/s12160-013-9486-6
Mikkelsen D B, Pedersen C, Højbjerg T, Schønheyder H C. Culture of multiple peroperative biopsies and diagnosis of infected knee arthroplasties. APMIS 2006; 114: 449-52. doi: 10.1111/j.1600-0463.2006.apm_428.x. DOI: https://doi.org/10.1111/j.1600-0463.2006.apm_428.x
Yi Z, Xu X, Meng X, Liu C, Zhou Q, Gong D, et al. Emerging markers for antimicrobial resistance monitoring. Chin Chem Lett 2023; 34: 108238. doi: 10.1016/j.cclet.2023.108238. DOI: https://doi.org/10.1016/j.cclet.2023.108238
Koprivnjak T, Peschel A. Bacterial resistance mechanisms against host defense peptides. Cell Mol Life Sci 2011; 68: 2243-54. doi: 10.1007/s00018-011-0716-4. DOI: https://doi.org/10.1007/s00018-011-0716-4
Pujol-Vila F, Villa R, Alvarez M. Nanomechanical sensors as a tool for bacteria detection and antibiotic susceptibility testing. Front Mech Eng 2020; 6: 44. doi: 10.3389/fmech.2020.00044. DOI: https://doi.org/10.3389/fmech.2020.00044
Cichos K H, Ruark R J, Ghanem E S. Isothermal microcalorimetry improves accuracy and time to bacterial detection of periprosthetic joint infection after total joint arthroplasty. J Clin Microbiol 2023; 61: e0089323. doi: 10.1128/jcm.00893-23. DOI: https://doi.org/10.1128/jcm.00893-23
Huang T, Zhang R, Li J. CRISPR-Cas-based techniques for pathogen detection: retrospect, recent advances, and future perspectives. J Adv Res 2023; 50: 69-82. doi: 10.1016/j.jare.2022.10.011. DOI: https://doi.org/10.1016/j.jare.2022.10.011
Chakraborty J, Chaudhary A A, Khan S-U-D, Rudayni H A, Rahaman S M, Sarkar H. CRISPR/Cas-based biosensor as a new age detection method for pathogenic bacteria. ACS Omega 2022; 7: 39562-73. doi: 10.1021/acsomega.2c04513. DOI: https://doi.org/10.1021/acsomega.2c04513
Meile S, Du J, Staubli S, Grossmann S, Koliwer-Brandl H, Piffaretti P, et al. Engineered reporter phages for detection of Escherichia coli, Enterococcus, and Klebsiella in urine. Nat Commun 2023; 14: 4336. doi: 10.1038/s41467-023-39863-x. DOI: https://doi.org/10.1038/s41467-023-39863-x
Meile S, Kilcher S, Loessner M J, Dunne M. Reporter phage-based detection of bacterial pathogens: design guidelines and recent developments. Viruses 2020; 12: 944. doi: 10.3390/v12090944. DOI: https://doi.org/10.3390/v12090944
Vasala A, Hytönen V P, Laitinen O H. Modern tools for rapid diagnostics of antimicrobial resistance. Front Cell Infect Microbiol 2020; 10: 308. doi: 10.3389/fcimb.2020.00308. DOI: https://doi.org/10.3389/fcimb.2020.00308
Zarnowiec P, Lechowicz L, Czerwonka G, Kaca W. Fourier transform infrared spectroscopy (FTIR) as a tool for the identification and differentiation of pathogenic bacteria. Curr Med Chem 2015; 22: 1710-18. doi: 10.2174/0929867322666150311152800. DOI: https://doi.org/10.2174/0929867322666150311152800
Rahman MH-U, Sikder R, Tripathi M, Zahan M, Ye T, Gnimpieba Z E, et al. Machine learning-assisted Raman spectroscopy and SERS for bacterial pathogen detection: clinical, food safety, and environmental applications. Chemosensors 2024; 12: 140. doi: 10.3390/chemosensors12070140. DOI: https://doi.org/10.3390/chemosensors12070140
Ho C-S, Jean N, Hogan C A, Blackmon L, Jeffrey S S, Holodniy M, et al. Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning. Nat Commun 2019; 10: 1-8. doi: 10.1038/s41467-019-12898-9. DOI: https://doi.org/10.1038/s41467-019-12898-9
Pankey G A, Sabath L. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis 2004; 38: 864-70. doi: 10.1086/381972. DOI: https://doi.org/10.1086/381972
Bernatová S, Samek O, Pilát Z, Šerý M, Ježek J, Jákl P, et al. Following the mechanisms of bacteriostatic versus bactericidal action using Raman spectroscopy. Molecules 2013; 18: 13188-99. doi: 10.3390/molecules181113188. DOI: https://doi.org/10.3390/molecules181113188
Mahlapuu M, Bjorn C, Ekblom J. Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 2020; 40: 978-92. doi: 10.1080/07388551.2020.1796576. DOI: https://doi.org/10.1080/07388551.2020.1796576
Patrulea V, Borchard G, Jordan O. An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections. Pharmaceutics 2020; 12. doi: 10.3390/pharmaceutics12090840. DOI: https://doi.org/10.20944/preprints202007.0375.v1
De Breij A, Riool M, Cordfunke R A, Malanovic N, de Boer L, Koning R I, et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med 2018; 10(423): eaan4044. doi: 10.1126/scitranslmed.aan4044. DOI: https://doi.org/10.1126/scitranslmed.aan4044
Dijksteel G S, Ulrich M M, Nibbering P H, Cordfunke R A, Drijfhout J W, Middelkoop E, et al. The functional stability, bioactivity and safety profile of synthetic antimicrobial peptide SAAP-148. J Microbiol Antimicrob 2020; 12: 70-80. doi: 10.5897/JMA2020.0437.
van Gent M E, Klodzinska S N, Drijfhout J W, Nielsen H M, Nibbering P H. Encapsulation in oleyl-modified hyaluronic acid nanogels substantially improves the clinical potential of the antimicrobial peptides SAAP-148 and Ab-Cath. Eur J Pharm Biopharm 2023; 193: 254-61. doi: 10.1016/j.ejpb.2023.11.005. DOI: https://doi.org/10.1016/j.ejpb.2023.11.005
Clokie M R, Millard A D, Letarov A V, Heaphy S. Phages in nature. Bacteriophage 2011; 1: 31-45. doi: 10.4161/bact.1.1.14942. DOI: https://doi.org/10.4161/bact.1.1.14942
Bertozzi Silva J, Storms Z, Sauvageau D. Host receptors for bacteriophage adsorption. FEMS Microbiol Lett 2016; 363. doi: 10.1093/femsle/fnw002. DOI: https://doi.org/10.1093/femsle/fnw002
Friman V P, Soanes-Brown D, Sierocinski P, Molin S, Johansen H K, Merabishvili M, et al. Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates. J Evol Biol 2016; 29: 188-98. doi: 10.1111/jeb.12774. DOI: https://doi.org/10.1111/jeb.12774
Eskenazi A L C, Wubbolts J, Hites M, Balarjishvili N, Leshkasheli L, Askilashvili L, et al. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat Commun 2022;13(1): 302. doi: 10.1038/s41467-021-27656-z. DOI: https://doi.org/10.1038/s41467-021-27656-z
Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, et al. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect Dis 2022; 22: e208-e220. doi: 10.1016/s1473-3099(21)00612-5. DOI: https://doi.org/10.1016/S1473-3099(21)00612-5
Khalifa A A, Hussien S M. The promising role of bacteriophage therapy in managing total hip and knee arthroplasty related periprosthetic joint infection, a systematic review. J Exp Orthop 2023; 10: 18. doi: 10.1186/s40634-023-00586-z. DOI: https://doi.org/10.1186/s40634-023-00586-z
Pirnay J P, Kutter E. Bacteriophages: it’s a medicine, Jim, but not as we know it. Lancet Infect Dis 2021; 21: 309-11. doi: 10.1016/s1473-3099(20)30464-3. DOI: https://doi.org/10.1016/S1473-3099(20)30464-3
Pirnay J-P, Djebara S, Steurs G, Griselain J, Cochez C, De Soir S, et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat Microbiol 2024; 9: 1434-53. doi: 10.1038/s41564-024-01705-x. DOI: https://doi.org/10.1038/s41564-024-01705-x
Ferry T, Onsea J, Roussel-Gaillard T, Batailler C, Moriarty T F, Metsemakers W-J. Bacteriophage therapy in musculoskeletal infections: from basic science to clinical application. EFORT Open Rev 2024; 9: 339-48. doi: 10.1530/eor-24-0042. DOI: https://doi.org/10.1530/EOR-24-0042
Drago L, Toscano M, Bottagisio M. Recent evidence on bioactive glass antimicrobial and antibiofilm activity: a mini-review. Materials (Basel) 2018; 11. doi: 10.3390/ma11020326. DOI: https://doi.org/10.3390/ma11020326
Zhou P, Garcia B L, Kotsakis G A. Comparison of antibacterial and antibiofilm activity of bioactive glass compounds S53P4 and 45S5. BMC Microbiol 2022; 22: 212. doi: 10.1186/s12866-022-02617-8. DOI: https://doi.org/10.1186/s12866-022-02617-8
Lindfors N, Geurts J, Drago L, Arts J, Juutilainen V, Hyvönen P, et al. Antibacterial bioactive glass, S53P4, for chronic bone infections: a multinational study. Adv Exp Med Biol 2017; 971: 81-92. doi: 10.1007/5584_2016_156. DOI: https://doi.org/10.1007/5584_2016_156
Van Vugt T A, Heidotting J, Arts J J, Ploegmakers J J, Jutte P C, Geurts J A. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study. J Bone Jt Infect 2021; 6: 413-21. doi: 10.5194/jbji-6-413-2021. DOI: https://doi.org/10.5194/jbji-6-413-2021
Moreno M G, Butini M E, Maiolo E M, Sessa L, Trampuz A. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis: real-time assessment by isothermal microcalorimetry. Colloids Surf B Biointerfaces 2020; 189: 110853. doi: 10.1016/j.colsurfb.2020.110853. DOI: https://doi.org/10.1016/j.colsurfb.2020.110853
Müller N, Kollert M, Trampuz A, Moreno M G. Efficacy of different bioactive glass S53P4 formulations in biofilm eradication and the impact of pH and osmotic pressure. Colloids Surf B Biointerfaces 2024; 239: 113940. doi: 10.1016/j.colsurfb.2024.113940. DOI: https://doi.org/10.1016/j.colsurfb.2024.113940
Hupa L. Composition-property relations of bioactive silicate glasses. In: Ylänen H, editor. Bioactive glasses: materials, properties and applications. 2nd ed. Amsterdam: Elsevier; 2018. DOI: https://doi.org/10.1016/B978-0-08-100936-9.00001-0
Vaiani L, Boccaccio A, Uva A E, Palumbo G, Piccininni A, Guglielmi P, et al. Ceramic materials for biomedical applications: an overview on properties and fabrication processes. J Funct Biomater 2023; 14. doi: 10.3390/jfb14030146. DOI: https://doi.org/10.3390/jfb14030146
LeGeros R Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 2002; 395: 81-98. doi: 10.1097/00003086-200202000-00009. DOI: https://doi.org/10.1097/00003086-200202000-00009
Kluin O S, Van der Mei H C, Busscher H J, Neut D. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opin Drug Deliv 2013; 10: 341-51. doi: 10.1517/17425247.2013.751371. DOI: https://doi.org/10.1517/17425247.2013.751371
McNally M A, Ferguson J Y, Scarborough M, Ramsden A, Stubbs D A, Atkins B L. Mid- to long-term results of single-stage surgery for patients with chronic osteomyelitis using a bioabsorbable gentamicin-loaded ceramic carrier. Bone Joint J 2022; 104: 1095-100. doi: 10.1302/0301-620x.104b9.bjj-2022-0396.r1. DOI: https://doi.org/10.1302/0301-620X.104B9.BJJ-2022-0396.R1
Palo N, Ray B, Lakhanpal M, Jeyaraman M, Choudhary G N, Singh A. Role of STIMULAN in chronic osteomyelitis: a randomised blinded study on 95 patients comparing 3 antibiotic compositions, bead quality, forming & absorption time. J Clin Orthop Trauma 2024; 52: 102426. doi: 10.1016/j.jcot.2024.102426. DOI: https://doi.org/10.1016/j.jcot.2024.102426
Kamphof R, Lima R N, Schoones J W, Arts J J, Nelissen R G, Cama G, et al. Antimicrobial activity of ion-substituted calcium phosphates: a systematic review. Heliyon 2023; 9. doi: 10.1016/j.heliyon.2023.e16568. DOI: https://doi.org/10.1016/j.heliyon.2023.e16568
Pijls B G, Sanders I, Kuijper E J, Nelissen R. Effectiveness of mechanical cleaning, antibiotics, and induction heating on eradication of Staphylococcus aureus in mature biofilms. Bone Joint Res 2022; 11: 629-38. doi: 10.1302/2046-3758.119.BJR-2022-0010.R1. DOI: https://doi.org/10.1302/2046-3758.119.BJR-2022-0010.R1
Chopra R, Shaikh S, Chatzinoff Y, Munaweera I, Cheng B, Daly S M, et al. Employing high-frequency alternating magnetic fields for the non-invasive treatment of prosthetic joint infections. Sci Rep 2017; 7: 7520. doi: 10.1038/s41598-017-07321-6. DOI: https://doi.org/10.1038/s41598-017-07321-6
Pijls B G, Sanders I, Kuijper E J, Nelissen R. Non-contact electromagnetic induction heating for eradicating bacteria and yeasts on biomaterials and possible relevance to orthopaedic implant infections: in vitro findings. Bone Joint Res 2017; 6: 323-30. doi: 10.1302/2046-3758.65.BJR-2016-0308.R1. DOI: https://doi.org/10.1302/2046-3758.65.BJR-2016-0308.R1
Pijls B G, Sanders I, Kuijper E J, Nelissen R. Segmental induction heating of orthopaedic metal implants. Bone Joint Res 2018; 7: 609-19. doi: 10.1302/2046-3758.711.BJR-2018-0080.R1. DOI: https://doi.org/10.1302/2046-3758.711.BJR-2018-0080.R1
Welling M M, Warbroek K, Khurshid C, van Oosterom M N, Rietbergen D D D, de Boer M G J, et al. A radio- and fluorescently labelled tracer for imaging and quantification of bacterial infection on orthopaedic prostheses : a proof of principle study. Bone Joint Res 2023; 12: 72-9. doi: 10.1302/2046-3758.121.BJR-2022-0216.R1. DOI: https://doi.org/10.1302/2046-3758.121.BJR-2022-0216.R1
Wang Q, Vachon J, Prasad B, Pybus C A, Lapin N, Chopra R, et al. Alternating magnetic fields and antibiotics eradicate biofilm on metal in a synergistic fashion. NPJ Biofilms Microbiomes 2021; 7: 68. doi: 10.1038/s41522-021-00239-y. DOI: https://doi.org/10.1038/s41522-021-00239-y
Verheul M, Drijfhout J W, Pijls B G, Nibbering P H. Non-contact induction heating and SAAP-148 eliminate persisters within MRSA biofilms mimicking a metal implant infection. Eur Cell Mater 2021; 43: 34-42. doi: 10.22203/eCM.v042a03. DOI: https://doi.org/10.22203/eCM.v042a03
Pijls B G, Sanders I, Kuijper E J, Nelissen R. Synergy between induction heating, antibiotics, and N-acetylcysteine eradicates Staphylococcus aureus from biofilm. Int J Hyperthermia 2020; 37: 130-6. doi: 10.1080/02656736.2019.1710269. DOI: https://doi.org/10.1080/02656736.2019.1710269
Cordero García-Galán E, Gomez-Barrena E, Lucía Ó, Esteban J, Medel-Plaza M, Rico-Nieto A, et al. In vivo reduction of biofilm seeded on orthopaedic implants. Bone Joint Res 2024; 13(12): 695-702. doi: 10.1302/2046-3758.1312.bjr-2024-0111.r2. DOI: https://doi.org/10.1302/2046-3758.1312.BJR-2024-0111.R2
Tsang S J, Morgan-Jones R, Simpson A. Debridement for prosthetic joint infections: future therapies. Bone Joint Res 2020; 9: 311-13. doi: 10.1302/2046-3758.96.BJR-2020-0238. DOI: https://doi.org/10.1302/2046-3758.96.BJR-2020-0238
Evans A, Kavanagh K A. Evaluation of metal-based antimicrobial compounds for the treatment of bacterial pathogens. J Med Microbiol 2021; 70. doi: 10.1099/jmm.0.001363. DOI: https://doi.org/10.1099/jmm.0.001363
Jiao J, Zhang S, Qu X, Yue B. Recent advances in research on antibacterial metals and alloys as implant materials. Front Cell Infect Microbiol 2021; 11: 1-19. doi: 10.3389/fcimb.2021.693939. DOI: https://doi.org/10.3389/fcimb.2021.693939
Lemire J A, Harrison J J, Turner R J. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol 2013; 11: 371-84. doi: 10.1038/nrmicro3028. DOI: https://doi.org/10.1038/nrmicro3028
Alt V, Chen A F. Antimicrobial coatings for orthopaedic implants: ready for use? J Bone Jt Infect 2020; 5: 125-7. doi: 10.7150/jbji.46508. DOI: https://doi.org/10.7150/jbji.46508
Kaur R, Kaur K, Alyami M H, Lang D K, Saini B, Bayan M F, et al. Combating microbial infections using metal-based nanoparticles as potential therapeutic alternatives. Antibiotics (Basel) 2023; 12. doi: 10.3390/antibiotics12050909. DOI: https://doi.org/10.3390/antibiotics12050909
van Hoogstraten S W, Fechter J, Bargon R, van Agtmaal J L, Peeters L C, Geurts J, et al. The antibacterial properties of a silver multilayer coating for the prevention of bacterial biofilm formation on orthopedic implants: an in vitro study. Coatings 2024; 14: 216. doi: 10.3390/coatings14020216. DOI: https://doi.org/10.3390/coatings14020216
Modaresifar K, Azizian S, Ganjian M, Fratila-Apachitei L E, Zadpoor A A. Bactericidal effects of nanopatterns: s systematic review. Acta Biomater 2019; 83: 29-36. doi: 10.1016/j.actbio.2018.09.059. DOI: https://doi.org/10.1016/j.actbio.2018.09.059
Ghosh S, Niu S, Yankova M, Mecklenburg M, King S M, Ravichandran J, et al. Analysis of killing of growing cells and dormant and germinated spores of Bacillus species by black silicon nanopillars. Sci Rep 2017; 7: 17768. doi: 10.1038/s41598-017-18125-z. DOI: https://doi.org/10.1038/s41598-017-18125-z
Hall Jr D C, Palmer P, Ji H-F, Ehrlich G D, Król J E. Bacterial biofilm growth on 3D-printed materials. Front Microbiol 2021; 12: 646303. doi: 10.3389/fmicb.2021.646303. DOI: https://doi.org/10.3389/fmicb.2021.646303
Kreve S, Dos Reis A C. Bacterial adhesion to biomaterials: what regulates this attachment? A review. Jpn Dent Sci Rev 2021; 57: 85-96. doi: 10.1016/j.jdsr.2021.05.003. DOI: https://doi.org/10.1016/j.jdsr.2021.05.003
Εkonomou S Ι, Soe S, Stratakos A C. An explorative study on the antimicrobial effects and mechanical properties of 3D printed PLA and TPU surfaces loaded with Ag and Cu against nosocomial and foodborne pathogens. J Mech Behav Biomed Mater 2023; 137: 105536. doi: 10.1016/j.jmbbm.2022.105536. DOI: https://doi.org/10.1016/j.jmbbm.2022.105536
Alkarri S, Bin Saad H, Soliman M. On antimicrobial polymers: development, mechanism of action, international testing procedures, and applications. Polymers (Basel) 2024; 16. doi: 10.3390/polym16060771. DOI: https://doi.org/10.3390/polym16060771
Xue Y, Xiao H, Zhang Y. Antimicrobial polymeric materials with quaternary ammonium and phosphonium salts. Int J Mol Sci 2015; 16: 3626-55. doi: 10.3390/ijms16023626. DOI: https://doi.org/10.3390/ijms16023626
Shankar S, Reddy J P, Rhim J W, Kim H Y. Preparation, characterization, and antimicrobial activity of chitin nanofibrils reinforced carrageenan nanocomposite films. Carbohydr Polym 2015; 117: 468-75. doi: 10.1016/j.carbpol.2014.10.010. DOI: https://doi.org/10.1016/j.carbpol.2014.10.010
Haktaniyan M, Bradley M. Polymers showing intrinsic antimicrobial activity. Chem Soc Rev 2022; 51: 8584-611. doi: 10.1039/d2cs00558a. DOI: https://doi.org/10.1039/D2CS00558A
Dallas P, Sharma V K, Zboril, R. Silver polymeric nanocomposites as advanced antimicrobial agents: classification, synthetic paths, applications, and perspectives. Adv Colloid Interface Sci 2011; 166: 119-35. doi: 10.1016/j.cis.2011.05.008. DOI: https://doi.org/10.1016/j.cis.2011.05.008
Arora A, Mishra A. Antibacterial polymers: a mini review. Materials Today: Proceedings 2018; 5: 17156-61. doi: 10.1016/j.matpr.2018.04.124. DOI: https://doi.org/10.1016/j.matpr.2018.04.124
Zhang H, Chiao M. Anti-fouling coatings of poly (dimethylsiloxane) devices for biological and biomedical applications. J Med Biol Eng 2015; 35: 143-55. doi: 10.1007/s40846-015-0029-4. DOI: https://doi.org/10.1007/s40846-015-0029-4
Keikhosravani P, Jahanmard F, Bollen T, Nazmi K, Veldhuizen E J A, Gonugunta P, et al. Antibacterial CATH–2 peptide coating to prevent bone implant–related infection. Adv Mater Technol 2023; 8. doi: 10.1002/admt.202300500. DOI: https://doi.org/10.1002/admt.202300500
Hancock S N, Yuntawattana N, Diep E, Maity A, Tran A, Schiffman J D, et al. Ring-opening metathesis polymerization of N-methylpyridinium-fused norbornenes to access antibacterial main-chain cationic polymers. Proc Natl Acad Sci U S A 2023; 120: e2311396120. doi: 10.1073/pnas.2311396120. DOI: https://doi.org/10.1073/pnas.2311396120
Sheet S, Vinothkannan M, Balasubramaniam S, Subramaniyan S A, Acharya S, Lee Y S. Highly flexible electrospun hybrid (polyurethane/dextran/pyocyanin) membrane for antibacterial activity via generation of oxidative stress. ACS Omega 2018; 3: 14551-61. doi: 10.1021/acsomega.8b01607. DOI: https://doi.org/10.1021/acsomega.8b01607
Kashef N, Hamblin M R. Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation? Drug Resist Updat 2017; 31: 31-42. doi: 10.1016/j.drup.2017.07.003. DOI: https://doi.org/10.1016/j.drup.2017.07.003
Riga E K, Vohringer M, Widyaya V T, Lienkamp K. Polymer-based surfaces designed to reduce biofilm formation: from antimicrobial polymers to strategies for long-term applications. Macromol Rapid Commun 2017; 38. doi: 10.1002/marc.201700216. DOI: https://doi.org/10.1002/marc.201700216
Alaoui Mdarhri H, Benmessaoud R, Yacoubi H, Seffar L, Guennouni Assimi H, Hamam M, et al. Alternative therapeutic approaches to conventional antibiotics: advantages, limitations and potential application in medicine. Antibiotics (Basel) 2022; 11. doi: 10.3390/antibiotics11121826. DOI: https://doi.org/10.3390/antibiotics11121826
Hou F, Chang Y, Huang Z, Han N, Bin L, Deng H, et al. Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics. BMC Microbiol 2019; 19: 308. doi: 10.1186/s12866-019-1681-6. DOI: https://doi.org/10.1186/s12866-019-1681-6
Seukep A J, Mbuntcha H G, Zeuko’o E M, Woquan L S, Nembu N E, Bomba F T, et al. Established antibacterial drugs from plants. Advances in Botanical Research. Amsterdam: Elsevier; 2023. p. 81-149. DOI: https://doi.org/10.1016/bs.abr.2022.08.005
Chen X, Zhou J, Qian Y, Zhao L. Antibacterial coatings on orthopedic implants. Materials Today Bio 2023; 19: 100586. doi: 10.1016/j.mtbio.2023.100586. DOI: https://doi.org/10.1016/j.mtbio.2023.100586
Sjollema J, Zaat S A J, Fontaine V, Ramstedt M, Luginbuehl R, Thevissen K, et al. In vitro methods for the evaluation of antimicrobial surface designs. Acta Biomater 2018; 70: 12-24. doi: 10.1016/j.actbio.2018.02.001. DOI: https://doi.org/10.1016/j.actbio.2018.02.001
Cartwright N, Munro E. The limitations of randomized controlled trials in predicting effectiveness. J Eval Clin Pract 2010; 16: 260-6. doi: 10.1111/j.1365-2753.2010.01382.x. DOI: https://doi.org/10.1111/j.1365-2753.2010.01382.x
Kostis J B, Dobrzynski J M. Limitations of randomized clinical trials. Am J Cardiol 2020; 129: 109-15. doi: 10.1016/j.amjcard.2020.05.011. DOI: https://doi.org/10.1016/j.amjcard.2020.05.011
Grainger D W, van der Mei H C, Jutte P C, van den Dungen J J, Schultz M J, van der Laan B F, et al. Critical factors in the translation of improved antimicrobial strategies for medical implants and devices. Biomaterials 2013; 34: 9237-43. doi: 10.1016/j.biomaterials.2013.08.043. DOI: https://doi.org/10.1016/j.biomaterials.2013.08.043
Busscher H J, van der Mei H C, Subbiahdoss G, Jutte P C, van den Dungen J J, Zaat S A, et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med 2012; 4: 153rv110-153rv110. doi: 10.1126/scitranslmed.3004528. DOI: https://doi.org/10.1126/scitranslmed.3004528
Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta, GA: US Department of Health and Human Services; 2013.
Heidary M, Khosravi A D, Khoshnood S, Nasiri M J, Soleimani S, Goudarzi M. Daptomycin. J Antimicrob Chemother 2018; 73: 1-11. doi: 10.1093/jac/dkx349. DOI: https://doi.org/10.1093/jac/dkx349
Torres A, Kuraieva A, Stone G G, Cillóniz C. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur Respir Rev 2023; 32. doi: 10.1183/16000617.0117-2023. DOI: https://doi.org/10.1183/16000617.0117-2023
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Julia L van Agtmaal, Mariëlle Verheul, Lieve Vonken, Kato Helsen, Marian G Vargas Guerrero, Sanne W G van hoogstraten, Bianca J Hurck, Giulia Pilla, Isabell Trinh, Gert-Jan de Bruijn, Henrik P Calum, Mark G J de Boer, Bart G Pijls, Jacobus J.C. Arts
This work is licensed under a Creative Commons Attribution 4.0 International License.
